| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2 |
| 1 | ALLOPURINOL | 1 |
| 2 | ASPIRIN | 1 |
| 3 | ASPIRIN 325 MG | 1 |
| 4 | ASPIRIN 81 MG | 1 |
| 5 | BASILIXIMAB | 1 |
| 6 | BEVACIZUMAB | 1 |
| 7 | BROLUCIZUMAB | 1 |
| 8 | CAPECITABINE | 1 |
| 9 | CELECOXIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| 1 | BROLUCIZUMAB | 1 | 0.0003 |
| 2 | LIOTHYRONINE SODIUM | 1 | 0.0001 |
| 3 | PYRAZINAMIDE | 1 | 0.0001 |
| 4 | CLADRIBINE | 1 | 0.0001 |
| 5 | RIFAMPICIN | 1 | 0.0001 |
| 6 | ENTECAVIR | 1 | 0.0001 |
| 7 | BASILIXIMAB | 1 | 0.0001 |
| 8 | KETOPROFEN | 1 | 0.0001 |
| 9 | ISONIAZID | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 1 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 2 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Estrogen [EPC] | 2 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 5 | Progestin [EPC] | 2 | 0.0000 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |